| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_785aef5376e92b3280401f44b8f6233d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y111-01011 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y111-01011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 |
| filingDate |
2019-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72efaafa4d29a450102845bcdb6605be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a754a0715ae189104ecf9d780f8db7c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_772dfe1be6afa22554d9b0c7dfc61f57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_863724363ee6e902b089be3d42d817e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cc17a6fb83c913fe8e16d33cb48d213
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adc7504a97af404b6f40fd0d6b41f044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_844a355b376e588f827da1fbc91d1fe8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7f4819313c6d2649517ff176a120c55 |
| publicationDate |
2021-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11149257-B2 |
| titleOfInvention |
Ascorbate peroxidase mutant MaAPXI-M36K and application thereof |
| abstract |
The present invention provides an ascorbate peroxidase mutant MaAPX1 M36K and an application thereof, belonging to the technical field of biotechnology. An amino acid sequence of the mutant MaAPX1 M36K of the present invention is shown in SEQ ID NO. 3. In the present invention, the mutant MaAPX1 M36K reconstruction protein is obtained by the method of prokaryotic expression. It is found that the mutant MaAPX1 M36K improves catalytic efficiency by nearly 5 times, providing a technical reference for further study and application of APX1. |
| priorityDate |
2019-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |